000 | 01812 a2200541 4500 | ||
---|---|---|---|
005 | 20250514003017.0 | ||
264 | 0 | _c20010719 | |
008 | 200107s 0 0 eng d | ||
022 | _a0008-5472 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMeyers, M | |
245 | 0 | 0 |
_aRole of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses. _h[electronic resource] |
260 |
_bCancer research _cJul 2001 |
||
300 |
_a5193-201 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAdaptor Proteins, Signal Transducing |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xpharmacology |
650 | 0 | 4 | _aCarrier Proteins |
650 | 0 | 4 |
_aCell Death _xdrug effects |
650 | 0 | 4 |
_aColonic Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aCyclin B _xmetabolism |
650 | 0 | 4 | _aCyclin B1 |
650 | 0 | 4 | _aDNA Damage |
650 | 0 | 4 |
_aDNA Repair _xphysiology |
650 | 0 | 4 | _aDrug Resistance, Neoplasm |
650 | 0 | 4 |
_aFibroblasts _xcytology |
650 | 0 | 4 |
_aFloxuridine _xpharmacology |
650 | 0 | 4 |
_aFluorouracil _xpharmacology |
650 | 0 | 4 |
_aG2 Phase _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIntracellular Signaling Peptides and Proteins |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aMitosis _xdrug effects |
650 | 0 | 4 | _aMutL Protein Homolog 1 |
650 | 0 | 4 |
_aNeoplasm Proteins _xdeficiency |
650 | 0 | 4 | _aNuclear Proteins |
650 | 0 | 4 |
_aProteins _xmetabolism |
650 | 0 | 4 |
_aStaining and Labeling _xmethods |
650 | 0 | 4 | _aTumor Cells, Cultured |
650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xmetabolism |
650 | 0 | 4 | _aGADD45 Proteins |
700 | 1 | _aWagner, M W | |
700 | 1 | _aHwang, H S | |
700 | 1 | _aKinsella, T J | |
700 | 1 | _aBoothman, D A | |
773 | 0 |
_tCancer research _gvol. 61 _gno. 13 _gp. 5193-201 |
|
999 |
_c11360611 _d11360611 |